Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
CC transcript
Inv. presentation
Director comp.
Assertio Therapeutics, Inc (ASRT)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
04/22/2021
GN
Assertio Holdings, Inc. to Report First Quarter 2021 Financial Results After the Close of Markets on Thursday, May 6, 2021
02/12/2021
GN
Assertio Holdings, Inc. Announces Closing of Registered Direct Offering of $34.3 Million
02/10/2021
GN
Assertio Holdings, Inc. Announces Pricing of $34.3 Million Registered Direct Offering
02/05/2021
GN
Assertio Holdings, Inc. Announces Pricing of $14 Million Registered Direct Offering
02/03/2021
GN
Assertio Announces $5.0 Million Insurance Settlement and General Corporate Updates
12/29/2020
GN
Assertio Announces Transfer of Listing from Nasdaq Global Select Market to Nasdaq Capital Market
12/15/2020
GN
Assertio Announces Restructuring Plan and Leadership Changes
11/06/2020
GN
Assertio Reports Third Quarter 2020 Financial Results
08/07/2020
GN
Assertio Reports Second Quarter 2020 Financial Results
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy